Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy

Long, YR; Yu, XL; Chen, RQ; Tong, YL; Gong, LK

Gong, LK (通讯作者)，Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China.;Gong, LK (通讯作者)，Univ Chinese Acad Sci, Beijing, Peoples R China.;Gong, LK (通讯作者)，Chinese Acad Sci, Shanghai Inst Mat Med, Zhongshan Inst Drug Discovery, Zhongshan, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2022; 13 ():

Abstract

With programmed death 1/ligand 1 (PD-1/PD-L1) as the cornerstone, anti-PD antibodies have pioneered revolutionary immunotherapies for malignancies. Bu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索